Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
01/2012
01/25/2012EP2408779A1 Compounds and biological materials and uses thereof
01/25/2012EP2408778A1 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
01/25/2012EP2408777A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization
01/25/2012EP2408776A1 Use of a kinase inhibitor for the treatment of thymoma
01/25/2012EP2408763A2 Derivatives of n-ý(2-aza-bicycloý2.1.1¨hex-1-yl)-aryl-methyl¨-heterobenzamide, preparation thereof and application of same in therapeutics
01/25/2012EP2408742A1 Anthelmintic agents and their use
01/25/2012EP2328890B1 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors
01/25/2012EP2280974B1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
01/25/2012EP2010542B1 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridines as plk1 protein kinase inhibitors for the treatment of proliferative disorders
01/25/2012CN102334017A Method for proving authenticity using naphthalocyanine compound, signal transduction method, polymer welding method, method for producing lithographic printing plate, printing ink, toner, heat-shielding material, and method for producing naphthalocya
01/25/2012CN102333777A Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
01/25/2012CN102329334A 6H-indole[3, 2-b]quinoxaline derivative and organic light-emitting diode thereof
01/25/2012CN102329325A Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors
01/25/2012CN102329320A Method for synthesizing natural product (+/-)-folicanthine and intermediate product thereof
01/25/2012CN102329319A Novel crystal form for temozolomide, method for preparing temozolomide and medicinal composition of temozolomide
01/25/2012CN101691371B Pemetrexed thiocarbamide salt and preparation method thereof
01/25/2012CN101591341B Alkyl porphyrin compound, preparation and application thereof in field of medicaments and pesticides
01/24/2012US8101751 Reverse-turn mimetics and method relating thereto
01/24/2012US8101644 Pyrrolinone derivative and pharmaceutical composition comprising the same
01/24/2012US8101623 Substituted pyrrolo[2,3-d]pyrimidine as a protein kinase B inhibitor
01/24/2012US8101613 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
01/24/2012US8101325 Azo compound, curable composition, color filter, and method of producing the same
01/24/2012CA2526578C Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
01/24/2012CA2494340C Compounds with the bicyclo[4.2.1]nonane system for the treatment of flaviviridae infections
01/24/2012CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
01/19/2012WO2012009553A1 Aldose reductase inhibitors and uses thereof
01/19/2012WO2012009372A2 Triazolium carbene catalysts and processes for asymmetric carbon-carbon bond formation
01/19/2012WO2012009309A1 Compounds for the reduction of beta-amyloid production
01/19/2012WO2012007861A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
01/19/2012WO2012007455A1 Process for the preparation of organic salts
01/19/2012WO2012007416A1 Bicyclic pyrimidines
01/19/2012WO2012007409A1 N-substituted pyrrolidines
01/19/2012WO2012007375A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators
01/19/2012WO2012007345A2 Substituted imidazo[1,2-a]pyrimidines and -pyridines
01/19/2012WO2012007006A1 Triazolo- and pyrazoloquinazoline derivatives as pde10a enzyme inhibitor
01/19/2012WO2012006780A1 Phthalocyanine-serum albumin complex, method for preparation and use thereof
01/19/2012WO2012006680A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals
01/19/2012WO2011112766A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease
01/19/2012WO2011102640A3 Method for preparing sitagliptin and amine salt intermediates used therein
01/19/2012US20120016119 NOVEL PYRROLO(2,3-d)PYRIMIDINE COMPOUND
01/19/2012US20120015964 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
01/19/2012US20120015963 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS
01/19/2012US20120015962 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
01/19/2012US20120015943 Substituted hydroxamic acids and uses thereof
01/19/2012US20120015941 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds
01/19/2012US20120015940 Novel aminopyridine derivatives having aurora a selective inhibitory action
01/19/2012US20120015930 Substituted imidazoheterocycle derivatives
01/19/2012US20120015928 Amido Compounds And Their Use As Pharmaceuticals
01/19/2012US20120015926 Compounds for the treatment of inflammatory disorders
01/19/2012US20120015925 Novel benzothiazepine and benzothiepine compounds
01/19/2012US20120015920 Heterobicyclic metalloprotease inhibitors
01/19/2012US20120015052 P2x3 receptor antagonists for treatment of pain
01/19/2012US20120014874 Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis
01/19/2012US20120012826 Organic light-emitting device
01/19/2012US20120012822 Aromatic compound and method for producing same
01/19/2012DE102010027317A1 Metallkomplexe Metal complexes
01/19/2012DE102010027316A1 Metallkomplexe Metal complexes
01/19/2012CA2805294A1 Compounds for the reduction of beta-amyloid production
01/19/2012CA2805015A1 Bicyclic pyrimidines
01/19/2012CA2804845A1 Substituted imidazo[1,2-a]pyrimidines and -pyridines
01/19/2012CA2804640A1 Aldose reductase inhibitors and uses thereof
01/19/2012CA2802641A1 Pyrazolo [1, 5a] pyrimidine and thieno [3, 2b] pyrimidine derivatives as irak4 modulators
01/19/2012CA2801032A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
01/18/2012EP2407470A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
01/18/2012EP2407469A1 Salt of sitagliptin
01/18/2012EP2406264A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
01/18/2012EP2406263A1 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
01/18/2012EP2406258A1 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
01/18/2012EP2406255A1 4-oxadiazol-2 -yl- indazoles as inhibitors of p13 kinases
01/18/2012EP2406240A2 Inhibitors of beta-secretase
01/18/2012EP2406216A2 Halogenalkylmethylenoxy-phenyl-substituted ketoenols
01/18/2012EP1877411B1 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv
01/18/2012EP1656373B1 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokineantagonists
01/18/2012EP1506196B1 Pyrazolopyrimidines as sodium channel inhibitors
01/18/2012CN1976706B Inhibition of FGFR3 and treatment of multiple myeloma
01/18/2012CN102326273A Organic electroluminescent element
01/18/2012CN102325774A Acid addition salt of udenafil, preparation method thereof and phamaceutical composition comprising same
01/18/2012CN102325773A Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
01/18/2012CN102325772A Ring compound
01/18/2012CN102325765A Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
01/18/2012CN102321089A Screw ring alkaloid compound, preparation method thereof and application in the aspect of marine organism fouling resistance
01/18/2012CN102321088A Novel anti-schistosomiasis compound
01/18/2012CN102321087A Synthesis method of polycyclic imidazole medicines
01/17/2012US8097629 Dihydropyridinone derivatives
01/17/2012US8097628 Compounds
01/17/2012US8097621 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors
01/17/2012US8097619 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
01/17/2012US8097611 Sulfonyl-derivatives as novel or histone deacetylase
01/17/2012US8097609 Swallowtail motifs for imparting water solubility to porphyrinic compounds
01/17/2012US8096419 Compound
01/17/2012CA2657594C Pyrrolotriazine kinase inhibitors
01/17/2012CA2484640C Vitamin-mitomycin conjugates
01/12/2012WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors
01/12/2012WO2012006009A1 Metallation enhancements in tumor-imaging and pdt therapy
01/12/2012WO2012005354A1 Photochromic material
01/12/2012WO2012004604A1 Tetrazole compounds as calcium channel blockers
01/12/2012WO2012004373A1 Fused heterocyclic derivatives as s1p modulators
01/12/2012WO2012004258A1 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
01/12/2012WO2012003829A1 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof
01/12/2012WO2012003576A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators